Ohio Recreational Marijuana Sales Double Medical Sales $600M Since Launch

Medical and recreational cannabis markets across various U.S. states and Australia are experiencing significant growth and regulatory challenges. In Australia, concerns have arisen over malpractice in medicinal cannabis prescriptions, with some doctors issuing tens of thousands of prescriptions without proper patient assessments, prompting investigations by health authorities. Ohio's adult-use marijuana market, launched in August 2024, has quickly outpaced medical marijuana sales, generating over $600 million in sales and twice the daily revenue of medical dispensaries, while lawmakers seek stronger regulations on intoxicating hemp products like Delta-8 THC. In Washington, D.C., medical marijuana sales have nearly doubled since January 2025, but dispensaries transitioning from informal 'gifting' shops face financial difficulties due to heightened competition and regulatory hurdles. Arkansas reports a 6.4% increase in medical marijuana sales in the first half of 2025 compared to 2024, with growing patient participation and substantial state tax revenue directed towards medical research. These trends highlight the rapid expansion of cannabis markets alongside ongoing concerns about regulation, patient safety, and the need for responsible prescribing and sales practices.